Burden of Proof for Tolvaptan in ADPKD Journal Articles

authors

• Mustafa, Reem Adel
• Yu, Alan SL

status

• published 

publication date

• July 2018

has subject area

• 1103 Clinical Sciences (FoR)
• Antidiuretic Hormone Receptor Antagonists (MeSH)
• Clinical Trials, Phase III as Topic (MeSH)
• Humans (MeSH)
• Multicenter Studies as Topic (MeSH)
• Polycystic Kidney, Autosomal Dominant (MeSH)
• Tolvaptan (MeSH)
• Urology & Nephrology (Science Metrix)

published in

• American Society of Nephrology. Clinical Journal  Journal

keywords

• ADPKD
• Antidiuretic Hormone Receptor Antagonists
• Autosomal Dominant
• Benzazepines
• Biological Phenomena
• Chronic
• Clinical Trials, Phase III as Topic
• Cysts
• Humans
• Kidney Failure
• Multicenter Studies as Topic
• Polycystic Kidney
• Polycystic Kidney, Autosomal Dominant
• Tolvaptan
• United States
• Urinary Tract Physiological Phenomena
• chronic kidney disease
• clinical trial

Digital Object Identifier (DOI)

• 10.2215/cjn.00190118

start page

• 1107

end page

• 1109

volume

• 13

issue

• 7